• Mobile:
  • Tel:
  • Fax:86-21-56469616
  • URL:http://www.minstargroup.com
  • Province/state:Shanghai
  • City:Shanghai
  • Street:BUILDING 8, NO.1098, CHUANSHA ROAD, SHANGHAI, CHINA
  • MaxCard:
Home > Products >  H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH

H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH CAS NO.106612-94-6

  • Min.Order: 1 Gram
  • Payment Terms: T/T
  • Available Specifications:

  • Product Details

Keywords

  • GLP-1
  • Glucagon like peptide 1 (7-37)
  • Glucagon-relatedpeptide 1 (Rana catesbeiana), 3-L-glutamicacid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-31-glycine-32-de-L-lysine-

Quick Details

  • ProName: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-...
  • CasNo: 106612-94-6
  • Molecular Formula: C151H228N40O47
  • Appearance: white powder
  • Application: 106612-94-6
  • DeliveryTime: in stock
  • PackAge: according to the customer
  • Port: shanghai
  • ProductionCapacity: 1 Gram/
  • Purity: 98
  • Storage: room
  • Transportation: by sea air and courier
  • LimitNum: 1 Gram
  • Related Substances: 1
  • Residue on Ignition: 1
  • Heavy Metal: 1
  • Valid Period: 1
  • 1: 1
  • 1: 1

Superiority

lucagon-Like Peptide 1 Fragment 7-37 human (GLP-1-(7-37)) interacts with the GLP-1 receptor (GLP-1r). It mediates insulin release by stimulating the cyclic AMP accumulation in islet cells GLP-l(7-37) is a potential therapeutic agent due to its insulin-secretagogue functionality.
in vitro In vitro, truncated glucagon-like peptides [GLP-1(7-36)-amide and GLP-1(7-37)] increase insulin secretion in a glucose-dependent manner, and desensitization to the action of GLP-1(7-37) has been demonstrated acutely with high concentrations.
in vivo GLP-1(7-37) (0.5, 5 or 50 pmol/min/kg) infused during the second hour of a 2-hour 11-mM hyperglycemic clamp produces a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion in rats. Infusion of GLP-1(7-37) (5 pmol/min/kg) from 1 hour through 7 hours produces a sustained increase in plasma insulin concentration relative to levels in rats infused

Details

lucagon-Like Peptide 1 Fragment 7-37 human (GLP-1-(7-37)) interacts with the GLP-1 receptor (GLP-1r). It mediates insulin release by stimulating the cyclic AMP accumulation in islet cells GLP-l(7-37) is a potential therapeutic agent due to its insulin-secretagogue functionality.
in vitro In vitro, truncated glucagon-like peptides [GLP-1(7-36)-amide and GLP-1(7-37)] increase insulin secretion in a glucose-dependent manner, and desensitization to the action of GLP-1(7-37) has been demonstrated acutely with high concentrations.
in vivo GLP-1(7-37) (0.5, 5 or 50 pmol/min/kg) infused during the second hour of a 2-hour 11-mM hyperglycemic clamp produces a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion in rats. Infusion of GLP-1(7-37) (5 pmol/min/kg) from 1 hour through 7 hours produces a sustained increase in plasma insulin concentration relative to levels in rats infused

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog